Exhibit 99.1 Primoris Services Corporation Reports Fourth Quarter and Full Year 2025 Results Dallas, TX – Feb. 23, 2026 – Primoris Services Corporation (NYSE: PRIM) ("Primoris" or the "Company") today announced financial results for its fourth quarter and full year ended December 31, 2025, and provided the Company's initial outlook for 2026. For the full year 2025, Primoris reported the following highlights (1): For the fourth quarter of 2025, Primoris reported the following highlights (1): "Primoris conclu ...

Exhibit 99.1 Atlas Energy Solutions Announces Fourth Quarter and Year End 2025 Results Austin, TX – February 23, 2026 – Atlas Energy Solutions Inc. (NYSE: AESI) ("Atlas" or the "Company") today reported financial and operating results for the fourth quarter and fiscal year ended December 31, 2025. Year End 2025 Financial Highlights and Operational Updates Bud Brigham, Executive Chairman, said, "The growth case for Atlas is as exciting as it has ever been in my opinion. While waiting for Permian activity to ...

Financial Performance - Net sales for 2025 were $1,888.6 million, a 3% increase from $1,839.7 million in 2024, driven by acquisitions (approximately 4%) and favorable foreign currency translation (approximately 1%) [148]. - The company reported a net loss of $2.5 million or $0.14 net loss per diluted share in 2025, compared to a net income of $116.6 million or $6.51 earnings per diluted share in 2024 [149]. - Non-GAAP net income for 2025 was $123.2 million, down from $133.5 million in 2024, with non-GAAP earnings per diluted share at $7.02 compared to $7.44 in the previous year [149]. - Adjusted EBITDA for 2025 was $299.2 million, a decrease from $310.9 million in 2024, attributed to lower operating margins and increased selling, general and administrative expenses [149]. - Net cash flows from operating activities were $136.5 million in 2025, down from $204.6 million in 2024, primarily due to lower operating performance and higher cash outflows [151]. - The company declared cash dividends totaling $1.99 per share in 2025, amounting to $34.6 million, compared to $1.88 per share or $33.6 million in 2024 [134]. - The company reported a decrease in cash and cash equivalents to $179.8 million as of December 31, 2025, down from $188.9 million in 2024, reflecting a net cash flow decrease of $9.1 million [167]. - The Company recorded a pre-tax, non-cash impairment charge of $88.8 million for the EMEA reporting unit goodwill in Q2 2025 due to lower projected earnings and increased cost of capital [163]. - The Company achieved annualized cost savings of at least $20 million from its global cost and optimization program initiated in 2022, with an additional $40 million expected by the end of 2026 [177]. Acquisitions and Market Position - Quaker Houghton acquired Dipsol Chemicals Co., Ltd. in April 2025, enhancing its surface treatment solutions for automotive and industrial applications [21]. - The company’s acquisitions in 2025, including Natech and CSI, strengthen its market position in Europe and South Africa, respectively [22][23]. - Acquisition-related step-up inventory amortization for 2025 is $6.022 million, with no such charges in 2024 and 2023 [188]. Research and Development - Research and development expenses were $60.7 million in 2025, an increase from $57.3 million in 2024 and $50.3 million in 2023 [20]. - Quaker Houghton operates approximately 30 laboratory facilities worldwide focused on applied research and development [19]. Employee and Organizational Culture - The company has approximately 4,700 full-time employees globally as of December 31, 2025 [29]. - Quaker Houghton’s core values emphasize safety, integrity, and diversity, guiding its organizational culture and employee engagement initiatives [31]. - The company relies on attracting and retaining qualified personnel, with competition for talent intensifying in the current labor market [107]. Risks and Challenges - The company is subject to significant risks from demand fluctuations in the steel, automotive, aerospace, and industrial equipment industries, which could adversely affect liquidity and financial position [50]. - Forward-looking statements indicate potential impacts from economic downturns, tariffs, and supply chain constraints on business operations and financial condition [42]. - The company faces challenges in developing and gaining market acceptance for new products, which are essential for maintaining competitive position [53]. - Inflationary pressures and raw material cost increases are expected to impact the company's operations and customer demand [47]. - The company may face challenges in passing through raw material cost increases to customers, potentially impacting sales volumes [78]. - The specialty chemical industry faces supply shortages for certain raw materials, which could adversely affect the company's liquidity and financial position [79]. - Disruptions in the supply chain or loss of manufacturing facilities could lead to significant sales losses and negatively impact liquidity and financial results [80]. - The company is subject to stringent labor laws, and labor disputes could disrupt operations and negatively impact financial results [91]. - Environmental regulations and climate change risks could impose additional operational restrictions and costs, impacting financial performance [88]. - The company may face liabilities related to hazardous materials, which could result in significant financial exposure and operational disruptions [94]. Financial Obligations and Debt - As of December 31, 2025, the Company had outstanding borrowings of $859.7 million under its Credit Facility, with total net debt amounting to $691.4 million after accounting for cash and cash equivalents of $179.8 million [172]. - Total contractual cash obligations as of December 31, 2025, amounted to $1,069.1 million, including long-term debt of $869.8 million and interest obligations of $60.4 million [183]. - The Company has a share repurchase program authorized for up to $150 million, with approximately $59.2 million remaining under the program as of December 31, 2025 [179]. - The Company entered into $300.0 million notional amounts of three-year interest rate swaps to convert variable rate borrowings into a fixed rate obligation of 3.64% plus an applicable margin [174]. Cybersecurity and Compliance - The company is at risk of reputational damage and operational disruptions due to potential cybersecurity breaches and failures in information security [100]. - The company's Global Cyber Security team is responsible for identifying and managing cybersecurity risks, with personnel experienced in data security and privacy [120]. - The company has implemented a cybersecurity risk management program leveraging the NIST framework, which includes categories such as govern, identify, protect, detect, respond, and recover [122]. - All employees are required to complete periodic cybersecurity training, with additional specialized training for certain roles [128]. - The Audit Committee oversees management's approach to managing cybersecurity risks, with updates provided at least quarterly [119]. Tax and Legal Matters - The effective tax rate for 2025 was 350.1%, significantly impacted by the non-cash goodwill impairment charge, compared to 31.8% in 2024 [202]. - The gross liability for uncertain tax positions, including interest and penalties, was $14.2 million as of December 31, 2025 [178]. - The Company established a transition tax liability of $15.5 million for U.S. income taxes on undistributed earnings of non-U.S. subsidiaries, which has been fully paid as of December 31, 2025 [158]. - Pending legal proceedings, including tax and environmental matters, could adversely affect liquidity and reputation in the market [83].

Financial Performance - Q4 2025 net sales reached $468.5 million, a 6% increase from $444.1 million in Q4 2024, driven by acquisitions contributing 6% and favorable foreign currency translation of 2%[4] - Q4 2025 net income was $20.7 million, or $1.18 per diluted share, compared to $14.2 million or $0.81 per diluted share in Q4 2024, reflecting a year-over-year increase of 46% in net income[5] - Full year 2025 net sales totaled $1.89 billion, with a net loss of $2.5 million, including an $88.8 million impairment charge and $35.1 million in restructuring charges[6] - Full year non-GAAP net income was $123.2 million, with non-GAAP earnings per diluted share at $7.02, reflecting a decrease from $7.44 in the previous year[6] - Adjusted EBITDA for Q4 2025 was $71.9 million, an 11% increase from $64.8 million in Q4 2024, primarily due to higher net sales and improved operating margins[5] - Operating income for the full year 2025 was $53.0 million, down from $194.7 million in 2024, indicating a significant decline[32] - Net income attributable to Quaker Chemical Corporation for Q4 2025 was $20.7 million, up from $14.2 million in Q4 2024[32] - Non-GAAP net income for Q4 2025 was $28,857 thousand, compared to $23,570 thousand in Q4 2024, reflecting a strong performance in profitability[22] Cash Flow and Debt - The Company generated $136.5 million in operating cash flow for 2025, down from $204.6 million in 2024, primarily due to lower operating performance and increased cash outflows from restructuring[14] - As of December 31, 2025, total gross debt was $871.2 million, with cash and cash equivalents of $179.8 million, resulting in net debt of $691.4 million, equating to a net debt to trailing twelve months adjusted EBITDA ratio of approximately 2.3x[15] - Cash and cash equivalents decreased to $179.8 million in 2025 from $188.9 million in 2024, reflecting a liquidity contraction[34] - Net cash provided by operating activities decreased to $136,453 million in 2025 from $204,578 million in 2024[37] - Net cash used in investing activities increased to $214,119 million in 2025, compared to $76,420 million in 2024, primarily due to payments related to acquisitions[37] - Net cash provided by financing activities was $61,833 million in 2025, a recovery from a net cash used of $122,664 million in 2024[38] Segment Performance - The Asia/Pacific segment saw a 15% increase in net sales in Q4 2025 compared to Q4 2024, driven by new business wins, while the Americas segment remained flat[10] - Segment operating earnings for the Americas in Q4 2025 were $51,218 thousand, slightly up from $50,930 thousand in Q4 2024, while EMEA and Asia/Pacific segments also showed growth[27] Strategic Initiatives - The Company completed three strategic acquisitions in 2025, contributing positively to revenue growth[6] - Future outlook includes continued focus on strategic planning and potential acquisitions to drive growth and enhance market position[21] Impairment and Charges - The company reported a total impairment charge of $88,840 thousand for the year 2025, impacting overall profitability[27] - Restructuring and related charges rose to $35,130 million in 2025, compared to $6,530 million in 2024[37] - Impairment charges amounted to $88,840 million in 2025, indicating potential asset write-downs[37] Market Outlook - Looking ahead to 2026, the Company anticipates stable end markets in the first half, with potential growth in the latter half, supported by a disciplined focus on operations and cost control[8] Other Financial Metrics - Non-GAAP gross profit for Q4 2025 was $165,524 thousand, up from $156,200 thousand in Q4 2024, resulting in a non-GAAP gross margin of 35.3% compared to 35.2% in the previous year[21] - Non-GAAP operating income for Q4 2025 increased to $45,109 thousand from $40,453 thousand in Q4 2024, with a non-GAAP operating margin of 9.6% versus 9.1%[21] - Adjusted EBITDA for Q4 2025 was $71,861 thousand, an increase from $64,783 thousand in Q4 2024, leading to an adjusted EBITDA margin of 15.3% compared to 14.6%[22] - Total assets increased to $2.8 billion in 2025 from $2.6 billion in 2024, showing a growth of approximately 7.2%[34] - Long-term debt rose to $834.9 million in 2025, up from $669.6 million in 2024, indicating increased leverage[35] - Interest expense for Q4 2025 was $10,783 thousand, compared to $9,077 thousand in Q4 2024, indicating increased borrowing costs[27] - The effect of foreign exchange rate changes on cash resulted in a positive impact of $6,782 million in 2025, contrasting with a negative impact of $11,141 million in 2024[38] Shareholder Information - The basic weighted average common shares outstanding decreased to 17.3 million in Q4 2025 from 17.7 million in Q4 2024[32] - GAAP earnings per diluted share for Q4 2025 were $1.18, up from $0.81 in Q4 2024, while non-GAAP earnings per diluted share increased to $1.65 from $1.33[23] Company Overview - Quaker Houghton operates in over 25 countries, serving thousands of customers in various industries including steel, automotive, and aerospace[30]

HealthStream Announces Fourth Quarter and Full-Year 2025 Results Page 1 February 23, 2026 Exhibit 99.1 Contact: Scott A. Roberts Chief Financial Officer (615) 301-3182 ir@healthstream.com Media: Mollie Condra, Ph.D. Head, Investor Relations & Communications (615) 301-3237 mollie.condra@healthstream.com HealthStream Announces Fourth Quarter & Full-Year 2025 Results NASHVILLE, Tenn. (February 23, 2026)—HealthStream, Inc. (the "Company") (Nasdaq: HSTM), a leading healthcare technology platform company for clin ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________ FORM 10-K __________________________________ (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________ to______________ 001-32492 (Commission File Number) __________________________ ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025, or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: 001-16533 ProAssurance Corporation (Exact name of registrant as specified in its charter) Delaware 63-1261433 (I.R. ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 or ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-41051 BLACKBOXSTOCKS INC. (Exact name of registrant as specified in its charter) Nevada 45-3598066 (State or other juris ...

Financial Performance - Achieved record quarterly orders and revenue, both exceeding $1.0 billion[3] - Full year 2025 consolidated revenue totaled $3.8 billion, with 50% generated from recurring revenue[3] - Full year 2025 adjusted EBITDA was $600 million, representing a margin of 15.8 percent[5] - Full year 2025 loss from continuing operations was $50 million, with a margin of (1.3) percent[4] - Revenue for the three months ended December 31, 2025, was $1,008.0 million, a significant increase from $467.6 million in the same period of 2024, representing a growth of 115.5%[23] - Adjusted income from continuing operations for the twelve months ended December 31, 2025, was $333.1 million, up from $198.0 million in 2024, reflecting a growth of 68.2%[24] - Adjusted EBITDA from continuing operations for the twelve months ended December 31, 2025, was $600.4 million, compared to $295.0 million in 2024, marking an increase of 103.5%[28] - The company reported a net income of $53.1 million for the three months ended December 31, 2025, compared to a net loss of $7.0 million in the same period of 2024[23] - Net loss from continuing operations for 2025 was $49.7 million, a significant decline compared to a profit of $84.6 million in 2024[40] Growth and Projections - For 2026, JBT Marel expects consolidated revenue growth of 5-7 percent, including a 1 percent foreign exchange translation benefit[12] - Full year 2026 revenue guidance is set at $3,990 - $4,065 million[11] - Anticipated adjusted EPS for 2026 is between $8.00 - $8.50[11] - Adjusted EBITDA from continuing operations is projected to be between $675 million and $710 million for the full year 2026[52] - Revenue guidance for 2026 is set between $3,990 million and $4,065 million, indicating a potential growth in sales[52] - Diluted earnings per share from continuing operations is expected to be between $4.70 and $5.15 for 2026[48] Orders and Backlog - Year-end backlog for 2025 was approximately $1.4 billion[5] - Total inbound orders for the three months ended December 31, 2025, reached $1,042.7 million, up from $523.1 million in the same period of 2024, indicating a growth of 99.4%[23] - The orders backlog as of December 31, 2025, was $1,372.0 million, significantly higher than $720.5 million in the previous year[23] Cost and Debt Management - Realized year-over-year synergy savings of approximately $43 million in 2025, with expected savings of $60 million in 2026[9] - As of December 31, 2025, the company's net debt to trailing twelve months adjusted EBITDA was 2.9x[6] - Total debt as of Q4 2025 was $1,881.9 million, an increase of 629.8% from $252.1 million in Q4 2024[44] - Net debt stood at $1,714.0 million in Q4 2025, compared to only $23.7 million in Q4 2024, reflecting a substantial increase[44] - The bank total net leverage ratio is calculated at 2.6 as of December 31, 2025[46] Cash Flow and Assets - Free cash flow for 2025 was $249.8 million, up from $199.3 million in 2024, indicating a 25.4% increase[42] - Cash and cash equivalents from continuing operations decreased to $186.5 million at the end of 2025 from $1,228.4 million at the end of 2024[40] - Total assets increased to $8,196.8 million in 2025 from $3,413.8 million in 2024, representing a growth of 140.5%[38] Profitability Metrics - Gross profit margin decreased to 34.5% for the three months ended December 31, 2025, compared to 38.4% in the same period of 2024[23] - Operating income margin improved to 7.2% for the three months ended December 31, 2025, compared to 3.4% in the same period of 2024[23] - M&A related costs for the twelve months ended December 31, 2025, totaled $114.5 million, reflecting the company's ongoing investment in growth strategies[25]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K MANPOWERGROUP INC. (Exact name of registrant as specified in its charter) | WISCONSIN | | 39-1672779 | | --- | --- | --- | | (State or other jurisdiction of | | (I.R.S. Employer | | incorporation or organization) | | Identification No.) | | 100 MANPOWER PLACE, MILWAUKEE, WISCONSIN | | 53212 | | (Address of principal executive offices) | | (Zip Code) | | Registrant's telephone number, including area code: (414) 961-1000 | | | | ...